Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 1 | uM | 7 | 5000.00 | 1243.75 | 6813.00 | 7211.25 | 0.9448 | 0.9557 |
| BT-20 | Lapatinib | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 7367.00 | 7211.25 | 1.0216 | 1.0169 |
| BT-20 | Erlotinib | 10 | uM | 7 | 5000.00 | 1243.75 | 4573.00 | 7211.25 | 0.6342 | 0.6712 |
| BT-20 | Erlotinib | 19.9526 | uM | 7 | 5000.00 | 1243.75 | 4245.00 | 7211.25 | 0.5887 | 0.6228 |
| BT-20 | 17-AAG | 0.0016596 | uM | 7 | 5000.00 | 1243.75 | 7282.00 | 7211.25 | 1.0098 | 1.0077 |
| BT-20 | 17-AAG | 10 | uM | 7 | 5000.00 | 1243.75 | 2289.00 | 7211.25 | 0.3174 | 0.2720 |
| BT-20 | Linsitinib | 0.01 | uM | 7 | 5000.00 | 1243.75 | 7134.00 | 7211.25 | 0.9893 | 0.9915 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7099.00 | 7211.25 | 0.9844 | 0.9877 | |
| BT-20 | Linsitinib | 10 | uM | 7 | 5000.00 | 1243.75 | 5862.00 | 7211.25 | 0.8129 | 0.8431 |
| BT-20 | Linsitinib | 19.9526 | uM | 7 | 5000.00 | 1243.75 | 4558.00 | 7211.25 | 0.6321 | 0.6690 |
| BT-20 | Erlotinib | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 6353.00 | 7211.25 | 0.8810 | 0.9025 |
| BT-20 | 17-AAG | 0.0033113 | uM | 7 | 5000.00 | 1243.75 | 7000.00 | 7211.25 | 0.9707 | 0.9767 |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7129.00 | 7211.25 | 0.9886 | 0.9910 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 7319.00 | 7211.25 | 1.0149 | 1.0117 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 1.00 | 7211.25 | 0.0001 | -0.9398 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 1.00 | 7211.25 | 0.0001 | -0.9398 | |
| BT-20 | 0 | uM | 7 | 5000.00 | 1243.75 | 6448.00 | 7211.25 | 0.8942 | 0.9137 | |
| BT-20 | 17-AAG | 0.01 | uM | 7 | 5000.00 | 1243.75 | 4876.00 | 7211.25 | 0.6762 | 0.7140 |
| BT-20 | 17-AAG | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 2067.00 | 7211.25 | 0.2866 | 0.2218 |
| BT-20 | 17-AAG | 0.1 | uM | 7 | 5000.00 | 1243.75 | 2127.00 | 7211.25 | 0.2950 | 0.2357 |
| BT-20 | Erlotinib | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 6505.00 | 7211.25 | 0.9021 | 0.9203 |
| BT-20 | Erlotinib | 1 | uM | 7 | 5000.00 | 1243.75 | 5261.00 | 7211.25 | 0.7296 | 0.7661 |
| BT-20 | Linsitinib | 0.31623 | uM | 7 | 5000.00 | 1243.75 | 6819.00 | 7211.25 | 0.9456 | 0.9564 |
| BT-20 | Lapatinib | 3.1623 | uM | 7 | 5000.00 | 1243.75 | 5220.00 | 7211.25 | 0.7239 | 0.7607 |
| BT-20 | 17-AAG | 0.031623 | uM | 7 | 5000.00 | 1243.75 | 2586.00 | 7211.25 | 0.3586 | 0.3347 |